Search Results - "Mestice, Anna"
-
1
-
2
SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
Published in Blood cancer journal (New York) (14-12-2021)Get full text
Journal Article -
3
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia
Published in Journal of immunology research (04-11-2020)“…An emerging body of evidence demonstrates that defects in antileukemic effector cells in patients with acute myeloid leukemia (AML) can contribute to the…”
Get full text
Journal Article -
4
LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens
Published in Frontiers in immunology (23-10-2018)“…We have previously shown that through the production of high LIGHT levels, immune cells contribute to both osteoclastogenesis and bone destruction in Multiple…”
Get full text
Journal Article -
5
Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients
Published in Journal of immunology research (01-01-2018)“…Acute myeloid leukemia (AML) is widely considered a distinct clinical entity with a well-defined molecular and genetics-based prognosis. Particularly in a…”
Get full text
Journal Article -
6
Extra virgin olive oil extract rich in secoiridoids induces an anti-inflammatory profile in peripheral blood mononuclear cells from obese children
Published in Frontiers in nutrition (Lausanne) (26-10-2022)“…Obesity represents an important public health challenge of the twenty first century reaching epidemic proportions worldwide; this is especially true for the…”
Get full text
Journal Article -
7
Normal percentage of CD56bright natural killer cells in young patients with a history of repeated unexplained implantation failure after in vitro fertilization cycles
Published in Fertility and sterility (01-10-2007)“…Changes in endometrial leukocyte subpopulations and most of all in the percentage of uterine natural-killer cells (uNK), during the menstrual cycles, may have…”
Get full text
Journal Article -
8
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias
Published in European journal of haematology (01-02-2014)“…Nuclear invaginations, also referred to as fishmouth or cuplike nuclei, have long been identified in microgranular APL, myelomonocytic and monocytic AMLs. More…”
Get full text
Journal Article -
9
Concomitant cutaneous T-cell lymphoma and biclonal B-cell lymphoproliferative disorder
Published in Cytometry. Part B, Clinical cytometry (14-08-2024)Get full text
Journal Article -
10
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia
Published in Leukemia & lymphoma (23-02-2023)Get full text
Journal Article -
11
Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-06-2022)Get full text
Journal Article -
12
RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia
Published in Human pathology (01-10-2018)“…Most acute promyelocytic leukemia (APL) patients express PML-RARA fusion; in rare cases, RARA is rearranged with partner genes other than PML. To date, only 2…”
Get full text
Journal Article -
13
LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease
Published in Oncotarget (30-12-2014)“…LIGHT, a TNF superfamily member, is involved in T-cell homeostasis and erosive bone disease associated with rheumatoid arthritis. Herein, we investigated…”
Get full text
Journal Article -
14
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma
Published in JBMR plus (01-07-2024)“…Bone disease associated with multiple myeloma (MM) is characterized by osteolytic lesions and pathological fractures, which remain a therapeutic priority…”
Get full text
Journal Article -
15
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients
Published in Clinical lymphoma, myeloma and leukemia (01-11-2017)“…Allotransplant is crucial for improving survival in refractory/first relapsed AML patients. An overall response was achieved in 48 patients (44% of the whole…”
Get full text
Journal Article -
16
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Published in Transplantation and cellular therapy (01-11-2021)“…•Donor graft cellular components CD3 cells and regulatory T cells (Tregs) may be studied as a ratio (CD3/TregsR) to obtain a threshold value associated with…”
Get full text
Journal Article -
17
Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma
Published in Leukemia & lymphoma (01-07-2014)“…Abstract Classical Hodgkin lymphoma (cHL) is characterized by the presence of tumoral cells in a rich background of T and B cells, macrophages and other…”
Get full text
Journal Article -
18
Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study
Published in Annals of hematology (01-05-2019)“…In this study, we aimed at disclosing the main features of paroxysmal nocturnal hemoglobinuria (PNH) clones, their association with presentation syndromes, and…”
Get full text
Journal Article -
19
The Role of LIGHT in Multiple Myeloma-Bone Disease
Published in Blood (06-12-2014)“…Background. The TNF superfamily member LIGHT, known to play a major role in T-cell homeostasis, has been reported in erosive bone disease associated with…”
Get full text
Journal Article -
20
Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia
Published in Oncotarget (15-02-2014)“…Lymphoid enhancer-binding factor 1 (LEF1) is a downstream effector of the Wnt/ β-catenin signaling pathway. High LEF1 expression has been reported as a…”
Get full text
Journal Article